Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cyanation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111592533A reveals a high-yield route for fungicidal intermediates. Discover cost-effective synthesis and scalable manufacturing insights for global supply chains.
Advanced synthesis of Formula I compounds via palladium-catalyzed cyanation and stereoselective reduction for high-purity pharmaceutical intermediates.
Patent CN108349883B details a novel nickel-catalyzed route for agrochemical intermediates, offering significant cost reduction and scalable manufacturing advantages.
Novel cyanation route for 2-cyanophenylacetanilide ensures high purity and scalable production for global epilepsy drug supply chains.
Patent CN1144781C details a novel hydrocyanation method for C5 mononitriles using selective hydrogenation, offering significant cost reduction and improved catalyst recovery for industrial scale-up.
Patent CN102603570A reveals a novel one-step ionic liquid cyanation method. Achieve significant cost reduction in pharma intermediates manufacturing with high purity.
Patent CN116120226A details a safe, scalable route for 5-hydroxymethyl nicotinonitrile using potassium ferrocyanide, offering significant cost reduction in fine chemical manufacturing.
Patent CN116396275B reveals a one-pot cyanation strategy for Topiroxostat, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112279794A reveals an optimized synthesis for isothiocyanate liquid crystal monomers, offering high yield and purity for advanced display manufacturing.
Patent CN118851951A details a one-pot synthesis for aryl cyano hypervalent iodine salts, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN103274964B details a safe, metal-free route to alpha-cyanoamines using iodide catalysts, offering cost reduction and supply chain stability for pharma intermediates.
Patent CN1169143A details a novel liquid-phase hydrocyanation method using multidentate phosphite ligands, offering significant cost reduction in nylon precursor manufacturing and enhanced supply chain reliability.
Patent CN106748853B reveals high-yield asymmetric synthesis for Clopidogrel intermediates. Achieve substantial cost reduction and supply chain reliability.
Discover the catalyst-free synthesis of 3-thiocyanoimidazo[1,5-a]quinolines using elemental sulfur. A scalable, high-yield route for pharmaceutical intermediates.
Novel synthesis method reduces toxicity and cost for pharmaceutical intermediates. Safe scalable process ensures high purity and supply continuity for global buyers.
Patent CN106278860A reveals a mild synthesis route for 3-chloro-2,4-difluorobenzoic acid offering high purity and reduced waste for pharmaceutical intermediate manufacturing supply chains.
Patent CN101648890B details a novel synthesis of 2-fluoro-4-nitrobenzonitrile using diazotization, offering high purity and cost-effective manufacturing for API intermediates.
Advanced catalytic route for Nomegestrol intermediate ensures high purity and supply stability for pharmaceutical manufacturing partners seeking cost efficiency.
Patent CN101671300B details a green palladium-catalyzed route replacing toxic cyanides with potassium ferrocyanide, ensuring safer supply chains.
Patent CN112194620B reveals a high-purity route for ethionamide intermediates, eliminating isomers and ensuring cost reduction in API manufacturing.